Exelixis
EXEL
#1773
Rank
HK$73.76 B
Marketcap
HK$258.31
Share price
0.67%
Change (1 day)
51.87%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company